Importantly, unlike mutant KMT2C and KMT2D, overexpression of LSD1 is subjected to pharmacological intervention and is a viable target for enhancement of H3K4 methylation for bladder cancer interception. This evidence concerns the gene KDM1A and urinary bladder cancer.